3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester CAS: 212322-56-0
| Product Parameters | |
|---|---|
| Catalog No. | BK85D7 |
| CAS.RN | 212322-56-0 |
| Molecular Formula | C18H22N4O3 |
| Molecular Weight | 342.39 g/mol |
| Purity | NLT 98% |
Product Overview
Ethyl 3-[(3-amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionate is a structurally complex pharmaceutical intermediate widely used in the synthesis of antitumor, antiviral, and immunomodulatory drugs. As a key intermediate, this compound participates in multi-step reactions to construct the target molecule skeleton, making it suitable for structural modification and activity screening in the early stages of drug development. It can also be used for process optimization and quality control in small-scale, pilot-scale, and large-scale production stages, making it an important raw material for pharmaceutical companies in new drug development and process improvement.
Applications
- Synthesis of antitumor drugs
- Preparation of antiviral drug intermediates
- Synthesis of immunomodulator precursors
- Drug target research and structural modification
- Process route development and optimization
Quality & Supply Capability
English Name: 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester Properties: White to off-white solid with active functional groups including amino, methylamino, benzoyl, and pyridyl groups. It exhibits good chemical stability, is readily soluble in organic solvents, and is suitable for various organic synthesis reaction systems. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific requirements. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust the supply plan according to the customer's specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical team to provide customers with comprehensive technical support from laboratory research and development to industrial scale-up, helping customers efficiently advance process development, route optimization, and project transformation.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing a rich product line and professional R&D experience. Full-scale supply capabilities to meet diverse needs from laboratory to commercial production. Comprehensive quality control documentation to ensure product quality meets international standards. Customized synthesis and process optimization can be implemented according to customer requirements. Comprehensive process scale-up and project transformation technical support to improve customer R&D efficiency.
Intermediates of Dabigatran etexilate
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA028Z | Dabigatran etexilate API | 211915-06-9 |
| BK85D7 | 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester | 212322-56-0 |
| BK6E43 | 3-[[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]pyridin-2-ylaMino]propionic acid ethyl ester | 211915-84-3 |
| BK559K | N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride | 211914-50-0 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 212322-56-0, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.